PRINCETON, N.J., Oct. 29 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. , a company specializing in advanced wound care products, announced it will present at the upcoming Rodman & Renshaw Annual Global Investment Conference taking place at the New York Palace Hotel in New York City. The Company is scheduled to present on November 12 at 10:45 am in the Adams room located on the 4th floor.
Management will discuss the Company's business strategy and their latest advanced wound care products. A live webcast of the presentation can be viewed at:
http://www.wsw.com/webcast/rrshq14/dsci.ob/
The webcast will automatically be archived approximately three hours after the live event and will be available for 90 days through February 12, 2009.
More information on the Rodman & Renshaw 10th Annual Healthcare Conference can be found at: http://www.rodm.com/conferences?id=19
About Derma Sciences
Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY(TM), is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. Derma has two products in development: the BIOGUARD(TM) line of barrier gauze dressings, and DSC127, the company's novel angiotensin analog for accelerated wound healing and scar reduction. The barrier technology was licensed from Quick-Med in Q1 of 2007 and is pending its initial FDA marketing clearance. DSC127 was licensed from The University of Southern California in Q4 of 2007 and is entering into a Phase II study, with anticipated initial patient enrollment to begin in Q3 of 2008. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.
CONTACT: Edward J. Quilty, Chairman and CEO of Derma Sciences, Inc.,
+1-609-514-4744, equilty@dermasciences.com; or US Investors, Rudy Barrio of
Allen & Caron Inc, r.barrio@allencaron.com, or media, Brian Kennedy,
+1-212-691-8087, brian@allencaron.com, both of Allen & Caron Inc, for Derma
Sciences, Inc.
Web site: http://www.dermasciences.com/
http://www.rodm.com/conferences?id=19/
